SARS-CoV-2 genomics: An Indian perspective on sequencing viral variants

Andersen KG, Rambaut A, Lipkin WI, Holmes EC and Garry RF 2020 The proximal origin of SARS-CoV-2. Nat. Med. 26 450–452 Anderson EJ, Rouphael NG, Widge AT, Jackson LA, Roberts PC, Makhene M, Chappell JD, Denison MR, et al. 2020 Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults. N. Engl. J. Med. 383 2427–2438 Andreano E, Piccini G, Licastro D, Casalino L, Johnson NV, Paciello I, Dal Monego S, Pantano E et al. 2020 SARS-CoV-2 escape in vitro from a highly neutralizing COVID-19 convalescent plasma. bioRxiv https://doi.org/10.1101/2020.12.28.424451 Apolone G, Montomoli E, Manenti A, Boeri M, Sabia F, Hyseni I, Mazzini L, Martinuzzi D, et al. 2020 Unexpected detection of SARS-CoV-2 antibodies in the pre-pandemic period in Italy. Tumori J Azkur AK, Akdis M, Azkur D, Sokolowska M, van de Veen W, Brüggen MC, O’Mahony L, Gao Y, Nadeau K and Akdis CA 2020 Immune response to SARS-CoV-2 and mechanisms of immunopathological changes in COVID-19. Allergy Eur. J. Allergy Clin. Immunol. 75 1564–1581 Banu S, Jolly B, Mukherjee P, Singh P, Khan S, Zaveri L, Shambhavi S, Gaur N et al. 2020 A distinct phylogenetic cluster of indian severe acute respiratory syndrome Coronavirus 2 isolates. Open Forum Infect. Dis. 7 ofaa434 Basavaraju SV, Patton ME, Grimm K, Rasheed MA, Lester S, Mills L, Stumpf M, Freeman B, et al. 2020 Serologic testing of US blood donations to identify SARS-CoV-2-reactive antibodies. Clin. Infect. Dis Catanzaro M, Fagiani F, Racchi M, Corsini E, Govoni S and Lanni C 2020 Immune response in COVID-19: addressing a pharmacological challenge by targeting pathways triggered by SARS-CoV-2. Signal Transduct. Target. Ther. 5 1–10 COG-UK 2020 COG-UK update on SARS-CoV-2 Spike mutations of special interest-Report 1. https://www.cogconsortium.uk/wp-content/uploads/2020/12/Report-1_COG-UK_20-December-2020_SARS-CoV-2-Mutations_final_updated2.pdf DNA Pipelines R&D, Farr B, Rajan D, et al. 2020. COVID-19 ARTIC v3 Illumina library construction and sequencing protocol. protocols.io. https://doi.org/10.17504/protocols.io.bibtkann Elbe S and Buckland-Merrett G 2017 Data, disease and diplomacy: GISAID’s innovative contribution to global health. Glob. Challenges 1 33–46 European Centre for Disease Prevention and Control 2020 Rapid increase of a SARS-CoV-2 variant with multiple spike protein mutations observed in the United Kingdom. https://www.ecdc.europa.eu/sites/default/files/documents/SARS-CoV-2-variant-multiple-spike-protein-mutations-United-Kingdom.pdf European Centre for Disease Prevention and Control 2020 Risk related to spread of new SARS-CoV-2 variants of concern in the EU/EEA2 https://www.ecdc.europa.eu/en/publications-data/threat-assessment-brief-rapid-increase-sars-cov-2-variant-united-kingdom Global Initiative on Sharing All Influenza Data (GISAID) 2020 Clade and lineage nomenclature aids in genomic epidemiology studies of active hCoV-19 viruses. https://www.gisaid.org/references/statements-clarifications/clade-and-lineage-nomenclature-aids-in-genomic-epidemiology-of-active-hcov-19-viruses/ Greaney AJ, Loes AN, Crawford KHD, Starr TN, Malone KD, Chu HY and Bloom JD 2020 Comprehensive mapping of mutations to the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human serum antibodies. bioRxiv https://doi.org/10.1101/2020.12.31.425021 Hadfield J, Megill C, Bell SM, Huddleston J, Potter B, Callender C, Sagulenko P, Bedford T, Neher RA, et al. 2018 Nextstrain: real-time tracking of pathogen evolution. Bioinformatics 34 4121–4123 Hassan SS, Choudhury PP, Roy B and Jana SS 2020 Missense mutations in SARS-CoV2 genomes from Indian patients. Genomics 112 4622–4627 Hemida MG, Chu DK, Poon LL, Perera RA, Alhammadi MA, Ng HY, Siu LY, Guan Y, Alnaeem A, Peiris M, et al. 2014 MERS coronavirus in dromedary camel herd, Saudi Arabia. Emerg. Infect. Dis. 20 1231 Hodcroft EB, Hadfield J, Neher RA and Bedford T 2020 Year-letter genetic clade naming for SARS-CoV-2 on Nextstrain.org. https://nextstrain.org/blog/2020–06–02-SARSCoV2-clade-naming Hodcroft EB, Zuber M, Nadeau S, Crawford KHD, Bloom JD, Veesler D, Vaughan TG, Comas I et al. 2020 Emergence and spread of a SARS-CoV-2 variant through Europe in the summer of 2020 . medRxiv https://doi.org/10.1101/2020.10.25.20219063 ICMR 2020 India is the 5th country globally to isolate the COVID-19 virus strain. https://www.icmr.gov.in/pdf/press_realease_files/Press_Release_ICMR_13March2020.pdf Jolly B, Rophina M, Shamnath A, Imran M, Bhoyar RC, Divakar MK, Rani PR, Ranjan G et al. 2020 Genetic epidemiology of variants associated with immune escape from global SARS-CoV-2 genomes. bioRxiv https://doi.org/10.1101/2020.12.24.424332 Jolly B and Scaria V 2020 Phylovis - Genomic epidemiology of novel coronavirus in India. http://clingen.igib.res.in/genepi/phylovis/ Kemp SA, Collier DA, Datir R, Gayed S, Jahun A, Hosmillo M, Ferreira IA, Rees-Spear C et al. 2020 Neutralising antibodies drive Spike mediated SARS-CoV-2 evasion. medRxiv https://doi.org/10.1101/2020.12.05.20241927 Korber B, Fischer WM, Gnanakaran S, Yoon H, Theiler J, Abfalterer W, Hengartner N, Giorgi EE, et al. 2020 Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus. Cell 182 812–827 Kumar BK, Rohit A, Prithvisagar KS, Rai P, Karunasagar I and Karunasagar I 2021 Deletion in the C-terminal region of the envelope glycoprotein in some of the Indian SARS-CoV-2 genome. Virus Res. 291 198222 Li MY, Li L, Zhang Y and Wang XS 2020 Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect. Dis. Poverty 9 1–7 Li Q, Wu J, Nie J, Zhang L, Hao H, Liu S, Zhao C, Zhang Q, et al. 2020 The impact of mutations in SARS-CoV-2 spike on viral infectivity and antigenicity. Cell 182 1284–1294 MacKenzie JS and Smith DW 2020 COVID-19: a novel zoonotic disease caused by a coronavirus from China: what we know and what we don’t. Microbiol. Aust. 41 45–50 Moderbacher CR, Ramirez SI, Dan JM, Grifoni A, Hastie KM, Weiskopf D, Belanger S, Abbott RK, et al. 2020 Antigen-specific adaptive immunity to SARS-CoV-2 in acute COVID-19 and associations with age and disease severity. Cell 184 996–1012 MoHFW 2020 Genomic Surveillance for SARS-CoV-2 In India - Indian SARS-CoV-2 Genomics Consortium (INSACOG) 1–18. https://www.mohfw.gov.in/pdf/IndianSARSCoV2PDFGenomicsConsortiumGuidanceDocument.pdf Mueller AL, McNamara MS and Sinclair DA 2020 Why does COVID-19 disproportionately affect older people? Aging 12 9959–9981 Naveca F, Nascimento V, Souza V, Corado A, Nascimento F, Silva G, Costa A, Duarte D et al. 2020 Phylogenetic relationship of SARS-CoV-2 sequences from Amazonas with emerging Brazilian variants harboring mutations E484K and N501Y in the Spike protein. https://virological.org/t/phylogenetic-relationship-of-sars-cov-2-sequences-from-amazonas-with-emerging-brazilian-variants-harboring-mutations-e484k-and-n501y-in-the-spike-protein/585. Accessed 09 Feb 2021 Oude Munnink BB, Sikkema RS, Nieuwenhuijse DF, Molenaar RJ, Munger E, Molenkamp R, Van Der Spek A, Tolsma P, et al. 2020 Transmission of SARS-CoV-2 on mink farms between humans and mink and back to humans. Science Public Health England 2020 Investigation of novel SARS-COV-2 variant. Variant of Concern 202012/01. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/947048/Technical_Briefing_VOC_SH_NJL2_SH2.pdf Polack FP, Thomas SJ, Kitchin N, Absalon J, Gurtman A, Lockhart S, Perez JL, Pérez Marc G, et al. 2020 Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383 2603–2615 Radhakrishnan C, Divakar MK, Jain A, Viswanathan P, Bhoyar RC, Jolly B, Imran M, Sharma D et al. 2020 Initial insights into the genetic epidemiology of SARS-CoV-2 isolates from Kerala suggest local spread from limited introductions. bioRxiv https://doi.org/10.1101/2020.09.09.289892 Rambaut A, Holmes EC, Hill V and OTooleMcCroneRuisdu PlessisPybus AJCLO 2020 A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology. Nat. Microbiol. 5 1403–1407 Resende PC, Bezerra JF, de Vasconcelos RHT, Arantes I, Appolinario L, Mendonça AC, Paixao AC, Rodrigues ACD et al. 2021 Spike E484K mutation in the first SARS-CoV-2 reinfection case confirmed in Brazil, 2020. https://virological.org/t/spike-e484k-mutation-in-the-first-sars-cov-2-reinfection-case-confirmed-in-brazil-2020/584. Accessed 09 Feb 2021 Sabino EC, Buss LF, Carvalho MP, Prete CA, Crispim MA, Fraiji NA, Pereira RH, Parag KV et al. 2021 Resurgence of COVID-19 in Manaus, Brazil, despite high seroprevalence. The Lancet 397 452–455 https://doi.org/10.1016/S0140-6736(21)00183-5 Shang E and Axelsen PH 2020 The potential for SARS-CoV-2 to evade both natural and vaccine-induced immunity. bioRxiv https://doi.org/10.1101/2020.12.13.422567 Shereen MA, Khan S, Kazmi A, Bashir N and Siddique R 2020 COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. J. Adv. Res. 24 91–98 Singh P, Avvaru AK, Banu S, Sharma D and Sowpati DT 2020 Genome evolution analysis resource for COVID-19 (GEAR-19). https://data.ccmb.res.in/gear19/ Song HD, Tu CC, Zhang GW, Wang SY, Zheng K, Lei LC, Chen QX, Gao YW, et al. 2005 Cross-host evolution of severe acute respiratory syndrome coronavirus in palm civet and human. Proc. Natl. Acad. Sci. USA 102 2430–2435 Tang X, Wu C, Li X, Song Y, Yao X, Wu X, Duan Y, Zhang H, et al. 2020 On the origin and continuing evolution of SARS-CoV-2. Natl. Sci. Rev. 7 1012–1023 Tegally H, Wilkinson E, Giovanetti M, Iranzadeh A, Fonseca V, Giandhari J, Doolabh D, Pillay S et al. 2020 Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. bioRxiv https://doi.org/10.1101/2020.12.21.20248640 Thomson EC, Rosen LE, Shepherd JG, Spreafico R, da Silva Filipe A, Wojcechowskyj JA, Davis C, Piccoli L et al. 2020 The circulating SARS-CoV-2 spike variant N439K maintains fitness while evading antibody-mediated immunity. bioRxiv https://doi.org/10.1101/2020.11.04.355842 Turoňová B, Sikora M, Schürmann C, Hagen WJ, Welsch S, Blanc FE, von Bülow S, Gecht M, et al. 2020 In situ structural analysis of SARS-CoV-2 spike reveals flexibility mediated by three hinges. Science 370 203–208 Van Dorp L, Richard D, Tan CC, Shaw LP, Acman M and Balloux F 2020 No evidence for increased transmissibility from recurrent mutations in SARS-CoV-2. Nature 11 5986 Van Dorp L, Tan CC, Lam SD, Richard D, Owen C, Berchtold D, Orengo C and Balloux F 2020 Recurrent mutations in SARS-CoV-2 genomes isolated from mink point to rapid host-adaptation. bioRxiv https://doi.org/10.1101/2020.11.16.384743 Vasques Nonaka CK, Miranda Franco M, Gräf T, Almeida Mendes AV, Santana de Aguiar R, Giovanetti M and Solano de Freitas Souza B 2021 Genomic Evidence of a Sars-Cov-2 Reinfection Case With E484K Spike Mutation in Brazil Preprints https://doi.org/10.20944/preprints202101.0132.v1 Volz E, Mishra S, Chand M, Barrett JC, Johnson R, Geidelberg L, Hinsley WR, Laydon DJ et al. Transmission of SARS-CoV-2 Lineage B.1.1.7 in England: Insights from linking epidemiological and genetic data. https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-42-sars-cov-2-variant/ Voysey M, Clemens SA, Madhi SA, Weckx LY, Folegatti PM, Aley PK, Angus B, Baillie VL, et al. 2020 Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet Wang D, Hu B, Hu C, Zhu F, Liu X, Zhang J, Wang B, Xiang H, Cheng Z, Xiong Y and Zhao Y 2020 Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. J. Am. Med. Assoc. 323 1061–1069 Weisblum Y, Schmidt F, Zhang F, DaSilva J, Poston D, Lorenzi JC, Muecksch F, Rutkowska M, et al. 2020 Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. Elife 9 e61312 Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, et al. 2020 A new coronavirus associated with human respiratory disease in China. Nature 579 265–269 Yadav PD, Potdar VA, Choudhary ML, Nyayanit DA, Agrawal M, Jadhav SM, Majumdar TD, Shete-Aich A, et al. 2020 Full-genome sequences of the first two SARS-CoV-2 viruses from India. Indian J. Med. Res. 151 200–209 Zhang L, Jackson CB, Mou H, Ojha A, Peng H, Quinlan BD, Rangarajan ES, Pan A, et al. 2020 SARS-CoV-2 spike-protein D614G mutation increases virion spike density and infectivity. Nat. Commun. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, Si HR, Zhu Y, et al. 2020 A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579 270–273